Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$24.36 Mil
% of Total Estimate Gain
44.60%

Vestal Point Capital, LP's Soleno Therapeutics Inc Holding Summary

As of 2025-03-31, Vestal Point Capital, LP held - shares of Soleno Therapeutics Inc(SLNO), totaling N/A. This investment constitutes 0% of their stock portfolio, and Vestal Point Capital, LP now holds 0% of the outstanding Soleno Therapeutics Inc(SLNO) stock.

The initial trade took place in 2023Q4. And since then Vestal Point Capital, LP has made 1 purchases of SLNO, at an average price of $33.30, for a total of 1.64 Mil shares. In addition, there have been 4 sales at an average price of $48.15 for 1.64 Mil shares. Based on historical transaction data and SLNO's current price of $83.25, Vestal Point Capital, LP's estimated gain on his SLNO holdings is $24.36 Mil, reflecting a 44.60% gain to date.

Vestal Point Capital, LP SLNO ($83.25) Holding Chart

Vestal Point Capital, LP SLNO ($83.25) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1